MERSANA THERAPEUTICS

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 8 2023 15:05:52 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Topline Data from UPLIFT Clinical Trial in Patients with Platinum-Resistant Ovarian Cancer and Strategic Reprioritization

27 7 2023 06:06:23 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 7 2023 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials

15 6 2023 06:30:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 6 2023 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

24 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results

09 5 2023 06:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 5 2023 15:05:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference

03 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023

02 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting

26 4 2023 15:05:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 4 2023 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial

13 3 2023 06:30:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Provides Statement About SVB

10 3 2023 18:10:38 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 3 2023 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023

21 2 2023 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 2 2023 15:05:00 提供 Nasdaq GlobeNewswire

Mersana Therapeutics to Present at Upcoming Investor Conferences

02 2 2023 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Initiates Expansion Portion of UPGRADE-A Combination Clinical Trial in Platinum-Sensitive Ovarian Cancer

01 2 2023 07:00:01 提供 Nasdaq GlobeNewswire

Mersana Therapeutics Announces Initiation of Phase 1 Trial of XMT-2056 in HER2-Expressing Tumors

25 1 2023 07:00:01 提供 Nasdaq GlobeNewswire